id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-5570-0020,FDA,FDA-2017-D-5570,Recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) Waiver Applications for Manufacturers of In Vitro Diagnostic Devices Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2020-02-26T05:00:00Z,2020,2,2020-02-26T05:00:00Z,,2024-11-06T23:33:16Z,,1,0,09000064843b60b4
FDA-2017-D-5570-0019,FDA,FDA-2017-D-5570,Recommendations for Clinical Laboratory Improvement Amendments of 1988 Waiver Applications for Manufacturers of In Vitro Diagnostic Devices; Guidance for Industry and Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2020-02-26T05:00:00Z,2020,2,2020-02-26T05:00:00Z,,2020-02-26T14:53:23Z,2020-03860,0,0,09000064843b4ec1